Efficacy and safety of transthyretin gene silencer eplontersen in patients with transthyretin amyloid cardiomyopathy receiving stabiliser therapy in the CARDIO-TTRansform trial
30 August 2026 (14:00 - 14:15)
Organised by: 
Slides
About the speaker
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)
4 More presentations in this session
Doctor S. Dorbala (Boston, US)
Doctor Y. Hamatani (Boston, US)
Doctor J. Gillmore (Greater London, GB)
Access the full session
The Event
ESC Congress 2026
30 August 2026
14:00 CET
You may be interested in
Congress Presentation
Congress Session
Congress Presentation
Congress Presentation
